Holocene Advisors
VERA icon

Holocene Advisors’s Vera Therapeutics VERA Stock Holding History

Holocene Advisors’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,307,393
Closed -$66.2M – 985
2025
Q4 		$66.2M Buy
+1,307,393
New +$46.4M 0.14% 175
2025
Q2 		– Sell
-2,199,292
Closed -$52.8M – 888
2025
Q1 		$52.8M Buy
2,199,292
+323,329
+17% +$10.4M 0.15% 161
2024
Q4 		$79.3M Sell
1,875,963
-78,565
-4% -$3.48M 0.25% 114
2024
Q3 		$86.4M Buy
1,954,528
+158,451
+9% +$6.01M 0.35% 96
2024
Q2 		$65M Buy
1,796,077
+588,697
+49% +$23.4M 0.27% 113
2024
Q1 		$52.1M Buy
+1,207,380
New +$43M 0.19% 146

Other funds holding VERA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Holocene Advisors's VERA Position: Q1 2026 in Review

Holocene Advisors sold out of Vera Therapeutics (VERA) in Q1 2026, closing a stake of 1,307,393 shares — an estimated $66.2M sold.

Holocene Advisors first reported a position in VERA in Q1 2024 and held it in 6 quarters. The position peaked at $86.4M in Q3 2024. 229 funds tracked by Wall St. Rank hold VERA as of Q1 2026.

  • Holocene Advisors reported no remaining Vera Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Holocene Advisors sold 1,307,393 Vera Therapeutics shares in Q1 2026, an estimated $66.2M.
  • Holocene Advisors first reported a position in Vera Therapeutics in Q1 2024 and held it in 6 quarters.
  • Holocene Advisors's Vera Therapeutics position peaked at $86.4M in Q3 2024.
  • 229 funds tracked by Wall St. Rank held Vera Therapeutics as of Q1 2026.

Based on Holocene Advisors's 13F filing for Q1 2026, filed 15 May 2026.